期刊文献+

放射性核素脑显像与阿尔茨海默病 被引量:1

Radionuclide brain imaging and diagnosis of Alzheimer's disease
暂未订购
导出
摘要 阿尔茨海默病(Alzheimer’s disease,AD)的早期诊断仍是临床一大难题。大量研究表明放射性核素脑显像,特别是PET显像是一种极有前途的早期诊断方法。研究显示AD早期大脑顶颞叶局部脑血流和葡萄糖代谢减低。一项研究显示PET显像可较临床诊断包括脑电图和形态学影像技术等早2年半诊断AD,其准确性超过90%。最新研究瞄准了AD的病理学特征——神经元纤维缠结和老年斑的“活体病理学”诊断,一些研究者用18F—FDDNP PET显像来定位和定量AD患者脑内的神经元纤维缠结和老年斑,监测神经元纤维缠结和老年斑有助于AD的确诊及疗效判断。 Diagnosis of early Alzheimer's disease (AD) is still a clinical challenge,growing evidence indicated radionu-elide neuroimaging, especially positron emission computed tomography (PET), would be promising for the diagnosis of early AD. Studies showed reduction of cerebral blood flow and glucose metabolism occurring at the parietotemporal lobes of AD patients at the early stage. A study showed that PET detected AD with an accuracy greater than 90% 2. 5 years earlier than clinical diagnostic methods using electroencephalography, structural imaging studies and so on. Recent investigation aimed at senile plaques (SPs) and neurofibrillary tangles (NFTs) that were hallmark pathologies accompanying the neurodegeneration involved in AD. Some researchers used 2-(l-(6-[(2-18F]fluoroethyl) (methyl)amino]-2-naphthyl)ethylidene) malononitrile (C18F]FDDNP) , in conjunction with PET to determine the localization and load of NFTs and SPs in the brains of living AD patients. Monitoring SPs and NFTs development is expected to facilitate diagnostic of AD patients and assist in response-monitoring during experimental treatments.
出处 《第二军医大学学报》 CAS CSCD 北大核心 2003年第4期447-450,共4页 Academic Journal of Second Military Medical University
关键词 放射性核素 脑显像 阿尔茨海默病 早期诊断 Alzheimer's disease radionuclide imaging diagnostic application
  • 相关文献

参考文献7

二级参考文献13

  • 1Tatlidil R, New P, Mayberg H. FDG positron emission tomography in diffuse Lewy body disease:a case report[J]. Clin Nucl Med, 2000, 25(12):1004-1006.
  • 2Silverman DHS, Small GW,Phelps ME. Clinical value of neuroimaging in the diagnosis of dementia : sensitivity and specificity of regional cerebral metabolic and other parameters for early identification of Alzheimer's disease[J]. Clin Posit Imag, 1999, 2(3):119-130.
  • 3Frey KA, Minoshima S, Kuhl DE, et al. Neurochemical imaging of Alzheimer's disease and other degenerative dementias[J]. Q J Nucl Med, 1998,42: 166.
  • 4Scheltens P,Pasquier F,Weerts JGE,et al. Qualitative assessment of cerebral atrophy on MRI:Inter-and intra-observer reproducibility in dementia and normal aging[J]. Eur Neurol, 1997, 37:95-99.
  • 5Johnson KA, Jones K, Holman BL, et al. Preclinical prediction of Alzheimer's disease using SPECT [J].Neurology, 1998, 50:1563-1571.
  • 6Silverman DHS, Chang CY, Cummings JL, et al.Prognostic value of regional brain metabolism in evaluation of dementia: comparison with long-term clinical outcome[J]. J Nucl Med, 1999,40(Suppl): 5.
  • 7Duara R, Grady C, Haxby J, et al. Positron emisson tomography in Alzheimer's disease [J]. Neurology,1986, 36:879-887.
  • 8Minoshima S, Giordani B, Berent S, et al. Metabolic reduction in the posterior cingulate cortex in very early Alzheimer's disease with PET[J]. J Nucl Med, 1997,42:85-94.
  • 9Duara R,Barker W, Luis CA. Frontotemporal dementia and Azheimer's disease: differential diagnosis [J ].Dement Geriatr Cogn Dis,1999,10 (Suppl 1):37-42.
  • 10De Reuck J, Decoo D, Marchau M, et al. Positron emission tomography in vascular dementia[J]. J Neurol Sci, 1998, 154:1,55-61.

共引文献12

同被引文献47

  • 1Wang Y, Klunk WE, Huang GF, et al. Development of 123I-labelled Agents for Amyloid Imaging[J]. J Labelled Cpd Radiopharm, 2003, 46: S173.
  • 2Vanderghinste D, Eeckhoudt MV, Cleynhens J, et al. Synthesis and Preliminary Evaluation of 99mTc-BAT-thioflavine T Derivatives for in Vivo Visualization of Amyloid β[A]. Nicolini M, Mazzi U. Technetium, Rhenium and Other Metals in Chemistry and Nuclear Medicine[C]. Italy: SGE, 2002. 463~465.
  • 3Pelecanou M, Pirmettis I, Patsis G, et al. Tricarbonyl Complexes of Re and Tc With a Bifunctional Tridentate NNO Ligand Carrying the 2-Phenyl-Benzothiazole Moiety[J]. J Labelled Cpd Radiopharm, 2003, 46: S25.
  • 4Zhuang ZP, Kung MP, Hou C, et al. IBOX(2-(4′-dimethylaminophenyl)-6-iodobenzoxazole): a Ligand for Imaging Amyloid Plaques in the Brain[J]. Nucl Med Biol, 2001, 28: 887~894.
  • 5Ono M, Kung MP, Hou C, et al. Benzofuran Derivatives as Aβ-aggregate-specific Imaging Agents for Alzheimer's Disease[J]. Nucl Med Biol, 2002, 29: 633~642.
  • 6Kung MP, Hou C, Zhuang ZP, et al. IMPY: an Improved Thioflavin-T Derivative for in Vivo Labeling of β-Amyloid Plaques[J]. Brain Res, 2002, 956: 202~210.
  • 7Cai L, Chin FT, Pike VW, et al. Evaluation of 18F-labeled IMPY Derivatives as PET Radioligands for β-Amyloid in Alzheimer's Disease[J]. J Labelled Cpd Radiopharm, 2003, 46: S166.
  • 8Zhuang ZP, Kung MP, Wilson A, et al. Structure-activity Relationship of Imidazo[1,2-a]pyridines as Ligands for Detecting β-Amyloid Plaques in the Brain[J]. J Med Chem, 2003, 46: 237~243.
  • 9Agdeppa ED, Kepe V, Liu J, et al. Binding C-haracteristics of Radiofluorinated 6-dialkylamino-2-naphthylethylidene Derivatives as Positron Emission Tomography Imaging Probes for β-amyloid Plaques in Alzheimer's Disease[J]. J Neurosci, 2001, 21: RC189: 1~5.
  • 10Lee CW, Kung MP, Hou C, et al. Dimethylam-ino-fluorenes: Ligands for Detecting β-amyloid Plaques in the Brain[J]. Nucl Med Biol, 2003, 30: 573~580.

引证文献1

二级引证文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部